Labeling DNA Probes
In-situ Hybridization
DNA Microarrays
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 22, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Kirk J Hogan1, James K Burmester, Michael D Caldwell
1Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, B6/319 Clinical Sciences Center, 600 Highland Avenue, Madison, WI 53792, USA. khogan@wiscmail.wisc.edu
Perioperative genetic testing reveals significant patient heterogeneity, identifying unknown susceptibilities to complications like drug reactions and sepsis. This new platform detects multiple mutant alleles per patient, improving surgical safety.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: